Lobna A. Hassanin, A. M. Salama, Enaam A. Essa, M. A. Moniem
{"title":"某些营养品在氧化铝神经毒性实验动物模型中的潜在作用","authors":"Lobna A. Hassanin, A. M. Salama, Enaam A. Essa, M. A. Moniem","doi":"10.22192/IJARBS.2017.04.11.010","DOIUrl":null,"url":null,"abstract":"The present study aimed to evaluate neurorestorative potential of lecithin (L) and/or gallic acid (GA) in alleviating aluminum (Al)-induced neurotoxicity in rat brain. Rats were classified into seven groups: Group (1): served as control, Groups (2)&(3): received lecithin or gallic acid in a dose of 100 mg/kg body weight. Group (4): received Al in a dose of 300 mg/kg body weight, Group (5): received Al + lecithin, Group (6): received Al + gallic acid and Group (7): received Al + lecithin+ gallic acid. Rats treated orally for 28 days (5days/week). Al induced a significant increase in AChE activity, along with a significant decrease in dopamine (DA), norepinephrine (NE) and serotonin (5-HT) levels. Al treatment resulted in significant increase in malondialdehyde (MDA), nitric oxide (NO) and oxidized glutathione (GSSG) content. On the contrary, Al caused a significant decrease in glutathione (GSH) and GSH/GSSG ratio. As well as, it stimulates an apoptotic signaling program by increase of Bax, caspase-3 and Bax/Bcl-2 ratio accompanied with decrease of Bcl-2 in the tested brain areas. Histopathological examination confirms the biochemical results. Conclusively, treatment with lecithin and/or gallic acid can retrieve the effect of aluminum toxicities on the basis of cholinergic, dopaminergic, oxidative, and apoptotic status.","PeriodicalId":13830,"journal":{"name":"International Journal of Advanced Research in Biological Sciences","volume":"36 1","pages":"72-89"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Potential role of some nutraceuticals in neurotoxicity induced by aluminum oxide in experimental animal model\",\"authors\":\"Lobna A. Hassanin, A. M. Salama, Enaam A. Essa, M. A. Moniem\",\"doi\":\"10.22192/IJARBS.2017.04.11.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The present study aimed to evaluate neurorestorative potential of lecithin (L) and/or gallic acid (GA) in alleviating aluminum (Al)-induced neurotoxicity in rat brain. Rats were classified into seven groups: Group (1): served as control, Groups (2)&(3): received lecithin or gallic acid in a dose of 100 mg/kg body weight. Group (4): received Al in a dose of 300 mg/kg body weight, Group (5): received Al + lecithin, Group (6): received Al + gallic acid and Group (7): received Al + lecithin+ gallic acid. Rats treated orally for 28 days (5days/week). Al induced a significant increase in AChE activity, along with a significant decrease in dopamine (DA), norepinephrine (NE) and serotonin (5-HT) levels. Al treatment resulted in significant increase in malondialdehyde (MDA), nitric oxide (NO) and oxidized glutathione (GSSG) content. On the contrary, Al caused a significant decrease in glutathione (GSH) and GSH/GSSG ratio. As well as, it stimulates an apoptotic signaling program by increase of Bax, caspase-3 and Bax/Bcl-2 ratio accompanied with decrease of Bcl-2 in the tested brain areas. Histopathological examination confirms the biochemical results. Conclusively, treatment with lecithin and/or gallic acid can retrieve the effect of aluminum toxicities on the basis of cholinergic, dopaminergic, oxidative, and apoptotic status.\",\"PeriodicalId\":13830,\"journal\":{\"name\":\"International Journal of Advanced Research in Biological Sciences\",\"volume\":\"36 1\",\"pages\":\"72-89\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Advanced Research in Biological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22192/IJARBS.2017.04.11.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Advanced Research in Biological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22192/IJARBS.2017.04.11.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Potential role of some nutraceuticals in neurotoxicity induced by aluminum oxide in experimental animal model
The present study aimed to evaluate neurorestorative potential of lecithin (L) and/or gallic acid (GA) in alleviating aluminum (Al)-induced neurotoxicity in rat brain. Rats were classified into seven groups: Group (1): served as control, Groups (2)&(3): received lecithin or gallic acid in a dose of 100 mg/kg body weight. Group (4): received Al in a dose of 300 mg/kg body weight, Group (5): received Al + lecithin, Group (6): received Al + gallic acid and Group (7): received Al + lecithin+ gallic acid. Rats treated orally for 28 days (5days/week). Al induced a significant increase in AChE activity, along with a significant decrease in dopamine (DA), norepinephrine (NE) and serotonin (5-HT) levels. Al treatment resulted in significant increase in malondialdehyde (MDA), nitric oxide (NO) and oxidized glutathione (GSSG) content. On the contrary, Al caused a significant decrease in glutathione (GSH) and GSH/GSSG ratio. As well as, it stimulates an apoptotic signaling program by increase of Bax, caspase-3 and Bax/Bcl-2 ratio accompanied with decrease of Bcl-2 in the tested brain areas. Histopathological examination confirms the biochemical results. Conclusively, treatment with lecithin and/or gallic acid can retrieve the effect of aluminum toxicities on the basis of cholinergic, dopaminergic, oxidative, and apoptotic status.